Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 42385-977

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 42385-977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig-1 (Metformin Fig 1)

Fig-1 (Metformin Fig 1)
FDA Label Image

Fig-2 (Metformin Fig 2)

Fig-2 (Metformin Fig 2)
FDA Label Image

Fig-3 (Metformin Fig 3)

Fig-3 (Metformin Fig 3)
This is a description for metformin hydrochloride extended-release tablets, USP. It is indicated for institutional use only. The package contains 160 unit-dose tablets, each containing 500 mg of metformin hydrochloride. The dosage information is provided in the enclosed package insert. The package is not child-resistant, so a child-resistant container should be used if dispensed for outpatient use. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The product is manufactured by Laurus Generics Inc. and Laurus Labs Limited in India.*
FDA Label Image

Fig-4 (Metformin Fig 4)

Fig-4 (Metformin Fig 4)
FDA Label Image

Fig-5 (Metformin Fig 5)

Fig-5 (Metformin Fig 5)
FDA Label Image

Fig-6 (Metformin Fig 6)

Fig-6 (Metformin Fig 6)
FDA Label Image

Structure (Metformin Structure)

Structure (Metformin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.